🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 28/11/1977 | 0,0113 USD |
| 29/08/1977 | 0,0099 USD |
| 31/05/1977 | 0,0099 USD |
| 01/03/1977 | 0,0099 USD |
| 30/11/1976 | 0,0099 USD |
| 30/08/1976 | 0,0093 USD |
| 01/06/1976 | 0,0093 USD |
| 02/03/1976 | 0,0093 USD |
| 01/12/1975 | 0,0093 USD |
| 29/08/1975 | 0,0093 USD |
| 02/06/1975 | 0,0093 USD |
| 03/03/1975 | 0,0093 USD |
| 30/08/1974 | 0,0093 USD |
| 03/06/1974 | 0,0093 USD |
| 04/03/1974 | 0,0093 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 14/02/2012 | 36,36 | 36,49 | 36,21 | 36,46 | +0,26% | 0,76% | 11.704.378 |
| 13/02/2012 | 36,36 | 36,49 | 36,24 | 36,36 | +0,53% | 0,68% | 12.179.437 |
| 10/02/2012 | 36,20 | 36,27 | 36,05 | 36,17 | -0,63% | 0,61% | 11.026.113 |
| 09/02/2012 | 36,63 | 36,76 | 36,39 | 36,40 | -0,70% | 0,99% | 10.058.390 |
| 08/02/2012 | 36,78 | 36,83 | 36,47 | 36,66 | -0,54% | 0,99% | 11.877.194 |
| 07/02/2012 | 36,52 | 37,00 | 36,50 | 36,86 | +0,60% | 1,38% | 13.044.875 |
| 06/02/2012 | 36,46 | 36,64 | 36,38 | 36,64 | +0,08% | 0,71% | 11.561.850 |
| 03/02/2012 | 36,74 | 36,82 | 36,34 | 36,61 | -0,18% | 1,32% | 15.730.690 |
| 02/02/2012 | 37,16 | 37,19 | 36,26 | 36,68 | -0,49% | 2,49% | 21.778.174 |
| 01/02/2012 | 36,78 | 37,22 | 36,56 | 36,86 | +0,94% | 1,79% | 15.276.801 |
| 31/01/2012 | 37,19 | 37,20 | 36,44 | 36,52 | -1,59% | 2,05% | 17.268.525 |
| 30/01/2012 | 36,62 | 37,12 | 36,52 | 37,11 | +0,96% | 1,64% | 13.324.586 |
| 27/01/2012 | 36,96 | 37,02 | 36,47 | 36,76 | -0,67% | 1,50% | 12.702.389 |
| 26/01/2012 | 37,06 | 37,17 | 36,77 | 37,00 | +0,26% | 1,06% | 12.983.462 |
| 25/01/2012 | 36,80 | 37,01 | 36,51 | 36,91 | -0,26% | 1,37% | 15.170.010 |
| 24/01/2012 | 37,19 | 37,41 | 36,88 | 37,00 | +0,03% | 1,44% | 13.775.646 |
| 23/01/2012 | 37,18 | 37,31 | 36,91 | 36,99 | -1,10% | 1,08% | 14.147.895 |
| 20/01/2012 | 37,52 | 37,60 | 37,14 | 37,40 | -0,15% | 1,22% | 16.069.927 |
| 19/01/2012 | 37,12 | 37,62 | 36,96 | 37,46 | +1,00% | 1,80% | 17.341.046 |
| 18/01/2012 | 36,88 | 37,17 | 36,87 | 37,09 | +0,13% | 0,80% | 15.416.709 |
| 17/01/2012 | 36,77 | 37,11 | 36,61 | 37,04 | +1,30% | 1,35% | 17.349.326 |
| 13/01/2012 | 36,69 | 36,74 | 36,28 | 36,56 | -0,75% | 1,25% | 10.141.915 |
| 12/01/2012 | 36,85 | 36,91 | 36,66 | 36,84 | +0,52% | 0,67% | 10.407.898 |
| 11/01/2012 | 36,66 | 36,76 | 36,49 | 36,65 | -0,29% | 0,73% | 12.519.198 |
| 10/01/2012 | 36,98 | 37,02 | 36,64 | 36,76 | +0,34% | 1,03% | 11.911.778 |
| 09/01/2012 | 36,58 | 36,71 | 36,15 | 36,63 | -0,21% | 1,51% | 14.574.431 |
| 06/01/2012 | 36,98 | 36,98 | 36,67 | 36,71 | -0,70% | 0,83% | 17.530.630 |
| 05/01/2012 | 36,39 | 37,21 | 36,30 | 36,97 | +1,04% | 2,52% | 21.995.005 |
| 04/01/2012 | 36,50 | 36,58 | 36,16 | 36,58 | +0,10% | 1,15% | 14.374.682 |
| 03/01/2012 | 36,15 | 36,79 | 36,08 | 36,55 | +1,59% | 1,98% | 18.100.427 |